Investigators said the pharmaceutical manufacturer, one of the nation’s largest, had knowingly distributed opioids that were later resold illegally.
Category: Drugs (Pharmaceuticals)
-
Justice Dept. Sues AmerisourceBergen Over Role in Opioid Crisis
The New York Times – Business: -
Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen
The New York Times – Business:The report said the F.D.A.’s approval process for Aduhelm was “rife with irregularities” and criticized Biogen for setting an “unjustifiably high price.”
-
China’s Abrupt Covid Pivot Leaves Many Without Medicines
The New York Times – Business:Millions are desperate to get their hands on fever-reducing drugs and antivirals such as Pfizer’s Paxlovid as infections across China outpace supplies.
-
Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?
The New York Times – Business:Shortages and drug-resistant germs have renewed attention on a $6 billion proposal in Congress that would reconfigure the way antimicrobial drugs are developed and sold.
-
Alzheimer’s Drug May Benefit Some Patients, New Data Shows
The New York Times – Business:The drug, lecanemab, made by Eisai and Biogen, also carried risks of brain swelling and bleeding and should be studied further, a report of the findings said.
-
Flu and R.S.V. Increase Demand for Antibiotics and Antivirals
The New York Times – Business:An intense early flu season, coupled with a pediatric rise in respiratory illnesses, has left families frantically searching for medicines that are in short supply.
-
FTX’s In-House Performance Coach Is Just as Surprised as You Are
The New York Times – Business:George K. Lerner, a psychiatrist who has worked at the collapsed crypto exchange FTX since last year, said he had no knowledge of wrongdoing at the firm.
-
Walmart Agrees to Pay $3.1 Billion to Settle Opioid Lawsuits Nationwide
The New York Times – Business:The money would help pay for addiction treatment and drug education programs in communities across the United States.
-
Medication Treatment for Addiction Is Shorter for Black and Hispanic Patients, Study Finds
The New York Times – Business:The analysis of 15 years of prescription data showed that the racial disparities are widening.
-
CVS and Walgreens Near $10 Billion Deal to Settle Opioid Cases
The New York Times – Business:The agreement would resolve thousands of lawsuits over the retailers’ role in the addiction crisis. But a large majority of state, local and tribal governments must sign on for it to take effect.
-
With Promise of Legalization, Psychedelic Companies Joust Over Future Profits
The New York Times – Business:Cash rich start-ups are filing scores of patent claims on hallucinogens like magic mushrooms. Researchers and patient advocates worry high prices will make the therapies unaffordable.
-
FDA Panel Recommends Pulling Preterm Birth Drug From the Market
The New York Times – Business:The agency has weighed years of study that showed the treatment given accelerated approval 11 years ago was not effective.